Experiment summary for ENCSR000DSN
doi:10.17989/ENCSR000DSN
Summary
- Status
- released
- Assay
- ChIP-seq (Control ChIP-seq)
- Control type
- input library
- Biosample summary
- Homo sapiens cardiac muscle cell originated from H7 treated with 5 ng/mL Fibroblast growth factor 2 for 14 days, 10 ng/mL Bone morphogenetic protein 4 for 14 days, 6 ng/mL Activin A for 14 days
- Biosample Type
- in vitro differentiated cells
- Replication type
- unreplicated
- Description
- Control ChIP-seq on human H7-hESC differentiated 14 days
- Treatments
- 5 ng/mL Fibroblast growth factor 2 (UniProtKB:P09038) for 14 days, 10 ng/mL Bone morphogenetic protein 4 (UniProtKB:P12644) for 14 days, 6 ng/mL Activin A (CHEBI:81351) for 14 days
- Nucleic acid type
- DNA
- Fragmentation methods
- see document
- Platform
- Illumina Genome Analyzer
Attribution
ENCODE2 project
- Lab
- John Stamatoyannopoulos, UW
- Award
- U54HG004592 (John Stamatoyannopoulos, UW)
- Project
- ENCODE
- External resources
- Date submitted
- June 25, 2011
- Date released
- February 29, 2012
- Reference Epigenome
- ENCSR590OZV
- Treatment Time Series
- ENCSR831IZS , ENCSR114LRH , ENCSR182ORV
- Submitter comment
- Replicate 1,1 of this experiment was previously attributed to biosample ENCBS294AAA but it has since been corrected to the current biosample. Please note that the biosample term has remain unchanged.
Isogenic replicates
Isogenic replicate | Technical replicate | Summary | Biosample | Library |
|---|---|---|---|---|
| 1 | 1 | Homo sapiens female embryo cardiac muscle in vitro differentiated cells originated from H7 treated with 5 ng/mL Fibroblast growth factor 2 for 14 days, 10 ng/mL Bone morphogenetic protein 4 for 14 days, 6 ng/mL Activin A for 14 days | ENCBS395GPZ | ENCLB266ISA |